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Background: Hospitalization may be a particularly important time to promote smoking cessation, especially in the
immediate post-discharge period. However, there are few studies to date that shed light on the most effective or
cost-effective methods to provide post-discharge cessation treatment, especially among low-income populations
and those with a heavy burden of mental illness and substance use disorders.
Methods/design: This randomized trial will compare the effectiveness and cost-effectiveness of two approaches to
smoking cessation treatment among patients discharged from two urban public hospitals in New York City. During
hospitalization, staff will be prompted to ask about smoking and to offer nicotine replacement therapy (NRT) on
admission and at discharge. Subjects will be randomized on discharge to one of two arms: one arm will be proactive
multi-session telephone counseling with motivational enhancement delivered by study staff, and the other will be a
faxed or online referral to the New York State Quitline. The primary outcome is 30-day point-prevalence abstinence
from smoking at 6-month follow-up post-discharge. We will also examine cost-effectiveness from a societal and a payer
perspective, as well as explore subgroup analyses related to patient location of hospitalization, race/ethnicity, immigrant
status, and inpatient diagnosis.
Discussion: This study will explore issues of implementation feasibility in a post-hospitalization patient population, as
well as add information about the effectiveness and cost-effectiveness of different strategies for designing smoking
cessation programs for hospitalized patients.
Trial registration: Clinicaltrials.gov ID# NCT01363245
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Despite 40 years of progress in reducing the prevalence
of smoking, it remains the leading preventable cause of
death in the United States. Hospitals are an important
place to intervene, particularly for smokers of lower
socioeconomic status. Studies have shown follow-up
after hospital discharge to be efficacious in helping smo-
kers to quit, but there are still many questions about* Correspondence: ellie.grossman@nyumc.org
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reproduction in any medium, provided the orhow to structure the follow-up and how effective it is in
actual practice.
While smoking prevalence in the US has declined
from 24.1% in 1998 to 20.6% in 2008, it has not declined
consistently across all segments of the population [1].
There are large discrepancies by level of income and
education, as well as by racial and ethnic-minority status
[2]. High-risk groups are less likely to receive advice
from a provider to quit smoking, to use proven treat-
ment, or to quit successfully, compared with white smo-
kers and smokers above the poverty line [3].
Public safety net hospital systems are the main source
of care for many patients of lower socioeconomic status.
Developing programs to improve smoking cessationral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tial step toward achieving national health objectives and
should help reduce tobacco-related health disparities by
targeting the most economically disadvantaged.
Hospitalized patients, particularly in psychiatric units,
have a higher prevalence of smoking than the general
population. It is a time of enforced abstinence and
heightened vulnerability, making it a unique opportunity
to intervene. Of the few studies examining smoking ces-
sation among hospitalized patients, most have been effi-
cacy studies, using dedicated, specially trained smoking
cessation staff, with significant additional resources and
applying narrow eligibility criteria [4]. No studies have
included an entire hospital in a system-wide intervention
with follow-up post-discharge.
While post-discharge counseling needs to be provided
for at least 4 weeks after discharge [4], there is little evi-
dence about best practices in offering such post-
discharge services. Telephone counseling via Quitlines is
available in all 50 states, has broad reach, and is very ef-
fective [3,5]. However, statewide Quitlines are seldom
used within health care [6], both because facilities sel-
dom refer to telephone counseling [7] and patients re-
ferred seldom follow through [8]. Quitlines in 49 US
states allow health care providers to refer patients online
or via fax for proactive telephone counseling [9], which
may be a feasible and low-cost way to enroll smokers in
counseling [10-12]. Few studies have examined Quitlines
as a resource for hospitalized or recently hospitalized
patients. In a study of surgical patients, referral to a
Quitline for post-discharge proactive cessation counsel-
ing was found to be feasible, acceptable to surgical
patients and staff, and inexpensive [13].
Although referral to a Quitline may be an inexpensive
method of ensuring post-discharge follow-up for hospita-
lized smokers, its use in this setting has never been com-
pared to a more intensive telephone counseling system. In
this trial, we aim to compare a more intensive telephone
counseling system to a simple referral to the state Quit-
line. The more intensive counseling system, while likely to
be more expensive for a hospital system to implement
than referral to the Quitline, may be more cost-effective if
it results in a higher quit rate. Post-discharge patients may
particularly benefit from a more intensive counseling ap-
proach, and they may require more or different attempts
to make contact and maintain treatment engagement than
is feasible for the Quitline.
Methods/design
Overview
We plan to perform a randomized controlled trial com-
paring the effectiveness and cost-effectiveness of two
approaches to smoking-cessation counseling after dis-
charge from the hospital. We will enroll smokers fromall inpatient units at two urban hospitals serving pre-
dominantly low-income populations (Bellevue Hospital
Center and the Veterans Affairs (VA) New York Harbor
Healthcare System). During hospitalization, all patients
will receive usual care: 1) screening, 2) brief counseling
by the nurse and/or doctor, and 3) access to nicotine-
replacement therapy (NRT). All patients will be offered
4 weeks of NRT on discharge and will be randomized to
one of two arms for post-discharge counseling: 1) inten-
sive, proactive telephone counseling (seven sessions over
6 to 8 weeks) from a service affiliated with the patient’s
hospital, or 2) faxed or online referral to the New York
State Quitline for one proactive counseling session, fol-
lowed by reactive counseling if patients call the Quitline
for additional sessions. The primary outcome is smoking
abstinence at 6-month follow-up post-discharge.
Setting
The two hospitals where we are performing our study
are the following:
1. Bellevue Hospital Center, the nation’s oldest public
hospital, is a core New York University School of Medi-
cine teaching facility serving a very diverse medically
underserved population. There are approximately 20,000
admissions/year to adult medical/surgical services, and
4,000 admissions to adult psychiatric units. Limited Eng-
lish proficiency is common (50 to 60%), and 40% of inpati-
ents are Hispanic, 30% African American, 10% Asian and
17% Caucasian. The prevalence of smoking is 25% for in-
patient non-psychiatric services and 55 to 60% for the psy-
chiatric units. Among the smokers, the language
breakdown is: English 48%, Spanish 27%, Mandarin 13%,
Cantonese 8%, and other/unknown 4%. One in three
patients is uninsured, and this number is increasing (by
8% from 2007 to 2008). Among inpatients, 60% have Me-
dicaid, 15% Medicare, and 8% commercial insurance.
2. The Manhattan campus of the VA New York Har-
bor Healthcare System (Manhattan VA), also a core New
York University teaching facility, serves primarily low in-
come veterans in Manhattan and the surrounding areas.
There are approximately 4,000 admissions/year to the
medical/surgical services and 1,000 to psychiatry. Ap-
proximately 60% of inpatients are Caucasian, 31% are
African American, and 17% are Hispanic or Latino; most
(61%) have a high school education or less.
Both sites use a fully electronic medical record (EMR)
system [14,15]. The EMRs at both sites include a wide
range of clinical reminders to increase adherence to prac-
tice guidelines (including smoking cessation), and the level
of guideline adherence is measured routinely [16-18].
Participants
We plan to recruit all adult smokers admitted to the two
hospitals (see Figure 1 for flow diagram). Inclusion
Figure 1 Consortium of Hospitals Advancing Research on Tobacco (CHART) CONSORT 2011 flow diagram.
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the prior 30 days, 3) have an active US phone number,
and 4) able to provide consent in English, Spanish or
Mandarin (Table 1). We chose these three languages as
it will allow us to approach nearly 90% of smokers at
Bellevue and all smokers at the Manhattan VA. Patients
will be excluded if they use only smokeless tobacco or
products such as betel, are pregnant or breastfeeding,
are discharged to an institution (for example, jail/prison,
nursing home, long-term psychiatric facility), or do nothave the cognitive or physical ability to enroll or partici-
pate in the study.
Outcome measures
Our primary outcome will be 30-day point-prevalence
abstinence from smoking, as measured at 6-month
follow-up post-discharge via participant self-report. We
will perform this assessment via telephone survey. Our
hypotheses are that, compared to control (Quitline),
multisession phone counseling patients will have higher
Table 1 Eligibility criteria
Inclusion Exclusion criteria - patients will be excluded if they:
Age≥ 18 years* Use only smokeless tobacco or products such as betel
Smoked tobacco during the prior 30 days* Are pregnant or breastfeeding
Have an active US phone number Are discharged to an institution (for example, jail/prison,
nursing home, long-term psychiatric facility)
Able to provide consent in
English, Spanish, or Mandarin
Do not have the cognitive or physical ability to enroll or
participate in the study*
*Common to all Consortium of Hospitals Advancing Research on Tobacco (CHART) trials.
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and more quit attempts.
Secondary outcomes are biochemically validated abstin-
ence from smoking at 6-month follow-up (as measured by
salivary cotinine mailed in for collection via a protocol
described more fully elsewhere [19]) and smoking abstin-
ence at 12-month post-discharge follow-up (as measured
by participant self-report on telephone survey). For pre-
specified subgroup analyses, we will compare outcomes by
participant race/ethnicity, immigrant status, inpatient
diagnosis, and location of hospitalization.
As an exploratory sub-study, we will examine patient
use of text messaging and interest in a cessation interven-
tion using this technology. Given the mobility and relative
youth of our population, text messaging could be an ef-
fective way to reach these patients. The aims of this ex-
ploratory study are to assess: 1) the prevalence of regular
text messaging use, and 2) interest in counseling delivered
via text messaging.
Cost-effectiveness outcomes
As a companion to our effectiveness study, we will com-
pare the cost-effectiveness of the two intervention arms
from both a societal and a payer perspective. Our hypoth-
esis is that the intensive telephone counseling intervention
will have incremental cost-effectiveness ratios consistent
with current standards of health care value in the US.
Co-variables of interest
Covariables of interest are found in Table 2. Among these
variables will be sociodemographic measures; measures of
nicotine addiction, smoking cessation history, and interest
in quitting; comorbid mood symptoms and substance use
history, and medical history. We will also collect informa-
tion about the index hospitalization, including length of
stay, principal diagnoses, and procedure codes.
Facilitating participant retention
Performing a post-discharge intervention and assessing
follow-up smoking status may be particularly difficult in
this highly mobile, difficult-to-reach patient population.
On enrollment into the study, participants will be asked to
provide their own contact information (including multiplephone numbers) and also contact information for two
friends or family members who are likely to remain in
contact with them if they change their residence. To facili-
tate retention in the counseling intervention, counselors
will arrange the scheduled phone calls at times and phone
numbers that are convenient for the patients. We will per-
form brief interim follow-up assessments via phone at 2,
4, and 9 months post-discharge to confirm contact infor-
mation and assess smoking status (see Figure 2 for overall
study timeline). If we cannot reach a participant after three
attempts at any given time point for a follow-up assess-
ment, we will call the alternate contact people given at en-
rollment. If needed, we will also use participant email
contact information as a means to arrange phone commu-
nication. For participants we are still unable to contact, we
will check the hospital system’s medical record to try to
find any additional information.
Interventions
A. During hospitalization – usual care
Usual care includes screening, educational materials, and
access to NRT. We will provide at least two 1-hour
training sessions for nurses and physicians (residents
and staff ), covering both content (evidence for treat-
ment) and process (how and when to treat) – with peri-
odic brief refresher sessions. More importantly, the EMR
will provide guidance about treatment and reminders to
assess smoking status and treat as appropriate (for ex-
ample, with a link to ‘order entry’ to prescribe NRT
when a physician indicates that the patient has recently
smoked), since we have found that to be a more useful
approach to training [20]. This will help ensure all smo-
kers receive brief advice to quit while hospitalized.
On enrollment to the study, patients will receive infor-
mation about local cessation resources, NRT, and the
study itself, so they can read it while hospitalized. The
NRT information will include a troubleshooting number
to call in case of problems obtaining medication. We do
not expect many patients to have difficulty obtaining
NRT, but we want to ensure all patients have access to
it. Study staff will also provide information about local
cessation resources to all screened patients who do not
enroll in the study.













*Smoking: history, current use,
readiness to quit,
quit attempts, use of medications or
other treatments
X X X X X X
Health habits: alcohol, substance abuse X X X
Health status (HUI 3, EQ5D), medical conditions,
health-care utilization
X X X
Depression (PHQ-2) X X X
Text messaging preferences X
Other measures
*Biochemical validation X
Satisfaction with intervention components X
Intervention fidelity,
including contact with Quitline
X X X
*These measures (at least in part) are common to all Consortium of Hospitals Advancing Research on Tobacco (CHART) Trials.
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B1. Discharge medications
An EMR notification and/or physician-directed flyer atFigure 2 Schedule for intervention contacts and follow-up assessmenthe patient bedside will remind physicians to provide a
prescription for at least 4 weeks of NRT or other smok-
ing cessation medication on discharge (for all patients,
whether enrolled or not). Patients may receive any formts.
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ician. Bellevue patients without insurance will fill their
discharge prescriptions at the Bellevue discharge phar-
macy (which has NRT patch and gum and bupropion SR
on formulary). Bellevue patients with Medicaid or other
insurance will fill their prescriptions at pharmacies in
their local areas; they may have co-pays, which will vary
according to insurance type. VA patients will obtain
their medication via the VA pharmacy (which has NRT
patch/gum/lozenge, bupropion SR and varenicline on
formulary).
For patients enrolled in the study, counselors in both
arms of the study will assist patients in obtaining 4 weeks
of NRT patch or gum after discharge if they have
encountered problems and/or need help. In the ‘tele-
phone counseling’ arm, we have an algorithm that will
help counselors suggest appropriate NRT regimens de-
pending on patient tobacco use patterns. Again, the
manner of obtaining the NRT will vary, depending on
hospital and insurance status. For Bellevue patients with
Medicaid, a study physician will write an appropriate
prescription and mail it to the patient’s home for them
to fill at an outside pharmacy. For Bellevue patients with
private insurance, Medicare, or no insurance, study staff
will generate an order at drugstore.com, which will send
medication to the patient free of charge. For VA
patients, a study physician will write an appropriate pre-
scription and the VA mail-order pharmacy will send the
medication to the patient’s home as per VA outpatient
pharmacy protocol. Patients in the Quitline arm will
have access to NRT as per usual Quitline protocol.
B2. Discharge information
For all patients (whether enrolled or not), computerized
patient discharge instructions will include encourage-
ment to quit smoking and information about local
resources. Participating patients will have received add-




In January 2000, New York State launched a Smoker’s
Quitline (located at Roswell Park Cancer Institute, Buf-
falo, NY, USA) providing counseling in over 100 lan-
guages, with quit rates comparable [21] to those found
in published reports. The Quitline provides a proactive
counseling service referred to as the “Refer-to-Quit” pro-
gram. For patients in the Quitline arm, the Research As-
sistant will fax a referral or submit it electronically at the
time of randomization (shortly after discharge). The
Quitline will make up to five calls at different times of
the day to reach the patient. Once contacted, the patientreceives one 15 to 20 minute telephone counseling ses-
sion and a follow-up call to assess quit status (and check
that medication was received if it had been requested).
Patients can call the Quitline for additional follow-up
sessions.
C2. Telephone counseling arm
Patients in the Telephone Counseling arm will receive
telephone calls from study staff at days and times con-
venient for the patient. To establish the first post-
discharge contact, staff will call each patient up to 10
times during the 2 weeks following discharge. Once con-
tact has been made, the staff will complete tailored,
multi-session telephone counseling with the patients.
Our telephone counseling system includes proactive
counseling, a structured protocol, and relapse-sensitive
scheduling [22]. The content is based on Motivational
Interviewing and Problem Solving Therapy and addresses
behavioral and cognitive issues, including motivation, self-
efficacy, difficult situations, comorbid symptoms, coping
strategies, medication usage, and relapse prevention. The
program staff members use a structured protocol to main-
tain a record of each of the counseling calls for internal
quality assurance.
The planning session
The first counseling session lasts approximately 20 to 30
minutes and helps patients develop an individualized
plan to quit smoking or to remain abstinent (for those
patients who have already quit). Content areas include
smoking and quitting history, motivation, environmental
factors, planning, proper use of quitting aids, and setting
a quit date if needed.
Follow-up sessions
Follow-up calls will be weekly until a quit date is set and
at 1, 3, 7, 14, 30, and 42 days after each patient’s quit
date. The calls are intended to prevent relapse and to
help those who relapse resume quitting. Follow-up calls
(10 to 15 minutes) also use a counselors’ manual for
consistency and fidelity monitoring. Subjects are able to
call the program staff in between scheduled calls if
desired.
Randomization
We will randomize participants to one of the two arms
of the trial in a 1:1 ratio shortly after discharge, when in-
formation regarding discharge location becomes avail-
able in the medical record. Participants who have
enrolled in the study while they are in the hospital, but
who are then discharged to a nursing home or other fa-
cility where smoking is forbidden and patients cannot
leave to smoke, will be deemed ineligible and will not
undergo randomization. Allocation concealment will be
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until the patients are recruited into the trial and all base-
line measures are taken. We arranged our complete
randomization scheme before the study began, given the
expected number of participants from our power and
sample size analysis. The randomization was performed
using routines for random number generation available
in R Package for Scientific Computing (www.r-project.
org). To prevent a small number of patients in a particu-
lar study site from all receiving, by chance, the same
treatment, treatment assignment was randomized with
stratification on the study site (Bellevue versus Manhat-
tan VA). Study staff who perform follow-up assessments
are blinded to participants’ intervention assignment, as
are those performing the analyses of saliva cotinine. The
trial statistician performing the analyses of all study data
is masked to the treatment allocation.
Intervention standardization and fidelity
The Quitline has a standardized protocol and has well-
trained counselors answering its telephone calls and pro-
viding counseling. For the Telephone Counseling arm,
the telephone counselors will undergo an intensive ini-
tial training consisting of a) 5 hours of Motivational
Interviewing training with a clinical psychologist special-
izing in health psychology, and b) 20 to 30 hours of
training on the study’s clinical protocols. This training
will include role-plays with each other and with the
study’s counselor supervisor. After the counselor super-
visor has determined that a counselor has met the role-
play training objectives, the counselor will advance to
complete a series of standardized patient (SP) encoun-
ters. SP encounters will involve calling an actor trained
to portray a smoker enrolled in the study and complet-
ing planning and follow-up counseling sessions per
study protocol. The SP encounters will be audiotaped
and reviewed by a clinical psychologist and the study’s
counselor supervisor for adherence to trial protocols.
Each counselor will complete two to four SP encounters,
depending on their training needs as determined by the
study’s counselor supervisor.
To ensure intervention standardization and fidelity
after study implementation, a random sample of the
counselors’ phone calls will be audiotaped and reviewed
by a clinical psychologist and the study’s counselor
supervisor. Feedback on the calls will be given to coun-
selors verbally and documented using a standardized
form with scales indicating whether the counselor
adhered to Motivational Interviewing counseling techni-
ques and met the appropriate clinical objectives. Coun-
selors will also attend weekly group supervision
meetings with a clinical psychologist, during which time
the counselors’ active cases will be discussed with par-
ticular attention to difficult cases.Sample size
We will compare the 6-month abstinence rates of the
two arms of our trial. There are approximately 4,000
‘current smokers’ admitted to Bellevue non-psychiatric
services and 2,400 admitted to psychiatric services per
year. We anticipate enrolling 20% of the non-psychiatric
patients and 10% of the psychiatric patients – netting a
total enrollment of 1,040 Bellevue patients per year of
the study. At the VA, there are approximately 1,200
‘current smokers’ admitted to non-psychiatric services
and 500 admitted to psychiatric services per year. With
a similar anticipated enrollment rate, our projected en-
rollment at the VA is 290 patients per year of the study.
In total, we expect to enroll a total of approximately
3,000 patients over the 2.5 years of enrollment, or 1,500
per arm. We expect that the long-term abstinence rate
in the Quitline arm will be 5%. With 1,500 participants
in each treatment arm, the two-sided unpooled z-test of
proportions will have 80% power to detect 2.47% differ-
ence in abstinence rates between the two arms at the
0.05 significance level, meaning detecting an increase in
cessation rate to 7.47%.
Data analysis
Primary outcome - aim 1
Compare the effectiveness of two post-discharge models
of care: 1) Quitline referral, and 2) multi-session tele-
phone counseling.
Descriptive analysis techniques will be used to present
baseline characteristics of participants in each treatment
arm across the two centers and stratified by center. We
will use tests of means and proportions to compare char-
acteristics of the treatment groups and log-linear tests to
investigate treatment by center interaction. If the differ-
ences between the centers are not significant, the subse-
quent comparison of the primary outcome will be
performed between the two treatment groups across the
centers, otherwise it will be stratified on center. Baseline
characteristics of participants who drop out will be com-
pared with the other participants to examine whether the
drop out is at random. In the case of differential dropout
rates (for example, between treatment arms, between cen-
ters), we will further examine the factors that led to the
drop out. The two-sided z-test of proportions will be used
to compare the rates of abstinence from smoking at
6-month follow-up of the two treatment arms.
Primary outcome - aim 2
Cost-effectiveness analysis.
Following accepted standards for cost-effectiveness
analysis in health care [23], we will perform analyses from
a societal perspective (all expenditures, regardless of
whether from payers, patients or other sources). We will
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as this perspective is sometimes preferred by decision
makers. Costs will be discounted at a rate of 3%. Out-
comes will be expressed both in terms of cost per quality-
adjusted life year (QALY) and cost per life year.
Data inputs will include differential quit rates, along
with measures of their uncertainty. To estimate their im-
pact, we will develop a Markov model that will predict
differential incidence and impact of cardiovascular and
pulmonary disease, based on observed differential quit
rates of known duration, effect size, and statistical certi-
tude. In base case analyses, we will conservatively as-
sume that smoking cessation has no beneficial impact
on quality of life apart from decreasing the likelihood of
these longer-term adverse outcomes, although in sensi-
tivity analyses we can consider various scenarios regard-
ing this effect, including any changes in quality of life.
We will also explore different assumptions about dur-
ation of intervention effect.
Cost inputs will include the costs of staff time for the
in- and out-of-hospital components, including additional
staff training required to carry out the intervention. Staff
will prospectively track time trying to call each patient
and the duration of each counseling call (to value the
patient time-costs of participating). We will track phar-
macy expenditures for smoking-cessation medications.
We will use cigarette smoking frequency to estimate
cost-savings to patients from decreased cigarette con-
sumption. Finally, our analyses will include the potential
for downstream cost-savings (reduced incidence of car-
diovascular and pulmonary disease) and cost increase
(additional medical care).
By comparing incremental costs to incremental bene-
fits over a lifetime horizon, we will estimate the value of
this intervention, enabling its value to be compared to
alternative resource uses. In addition, we will compare
incremental cost-effectiveness ratios to accepted stan-
dards for favorable value in the US ($100,000 per life-
year, and/or $100,000 per QALY).
Secondary outcomes
We will use a similar approach for the secondary out-
comes, to explore the relationship of the intervention’s
effectiveness to specific patient characteristics. We will
investigate interaction between treatment and patient
race/ethnicity, immigrant status, hospital and type of
inpatient diagnosis (medical versus surgical versus psy-
chiatric). The interaction analysis will be performed
using log-linear tests and analysis of variance (ANOVA)
techniques. Assumptions will be checked, and non-
parametric alternatives and transformations considered.
Similar analyses will be performed stratifying by admis-
sion diagnosis (myocardial infarction, congestive heart
failure, pneumonia). Tests of trend in proportions andlongitudinal techniques will be used to compare mea-
sures taken over time (6- and 12-month follow-up). The
two-sided test of proportions will be employed to com-
pare the biochemically-verified rates of abstinence from
smoking at 6-month follow-up of the two treatment
arms. Other analyses regarding biochemical validation will
be performed as per common Consortium of Hospitals
Advancing Research on Tobacco (CHART) protocol [19].
To investigate patients’ use of text messaging via mo-
bile phones and interest in a cessation intervention using
this technology, we will examine prevalence of regular
text-messaging use and interest in counseling delivered
via text messaging. Descriptive analysis techniques and
tests of proportions will be used to present and compare
baseline characteristics of participants in the sub-study
within each center.
Discussion
In this study, we plan to compare the effectiveness and
cost-effectiveness of two interventions to promote smok-
ing cessation among hospitalized patients at urban pub-
lic hospitals, focusing on the post-discharge period. By
design, these interventions are easily generalizable and
potentially implementable at a wide variety of health-
care institutions. Our study targets a high-risk patient
population, including patients with mental illness who
have a particularly high prevalence of tobacco use.
In designing our study, we aim to balance the goals of
broad inclusivity and generalizability with optimizing reten-
tion and follow-up rates in a difficult-to-reach population.
Given that our intervention (counseling+medication) may
be of benefit even in patients who seem unmotivated to
quit smoking in the near future, we aim to include all smo-
kers – irrespective of stated desire to quit. Similarly, since
smoking cessation is likely to be beneficial to the health of
all smokers and systems-level change is often implemented
on a hospital-wide basis, we do not focus on patients in any
one disease category – rather, the entire institutions are
included.
The downside of aiming to be this inclusive in our
entry criteria is that we will likely enroll participants
who may be difficult to contact for follow-up post-
discharge. The population of these hospitals (especially
Bellevue’s) is highly mobile (both within New York City
and around the world) and has proven difficult to main-
tain contact with in prior projects targeting patients
post-discharge. Further, the smokers we enroll may be
ambivalent about quitting smoking and also about par-
ticipating in the study – making retention even more
difficult. To enhance retention rates we have added brief
follow-up calls at 2, 4, and 9 months post-discharge (in
addition to the planned outcome measurements at 6 and
12 months post-discharge). During these brief interim
calls, we will assess smoking status and confirm contact
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needed).
Additionally, information garnered from this study will
shed light on implementation concerns for programs of
post-discharge contact with hospitalized patients. We
will directly explore patients’ wishes regarding text mes-
saging in comparison to telephone counseling. We will
improve understanding of hospitalization as a true mo-
tivator for behavior change in the post-discharge period.
Furthermore, we will uncover real-world concerns with
accuracy of contact information, difficulties in reaching
patients via telephone due to schedule, issues in applying
standardized Quitline protocols to post-hospitalization
patients, and adding a post-discharge component to
usual hospital care. Since Joint Commission quality indi-
cators for smoking cessation include post-discharge care
[24] (and it is possible that they will extend this concept
into other areas), systematic information about feasibility
and implementation needs for such programs will be of
use even outside the clinical area of smoking cessation.
Our study is subject to several limitations. Our pri-
mary outcome is based on self-report, which likely will
falsely increase quit rates (as compared to biochemical
verification). Given the mobility of our patient popula-
tion and the fact that both of these hospitals are tertiary
referral centers within their respective networks (thus
potentially limiting post-discharge ongoing contact with
patients), we will likely have significant dropout and in-
ability to make contact to perform follow-up assess-
ments. There is also some variability in ‘usual care’
experienced by the patients. However, we would expect
all of these issues to be the same in both arms of the
study, and the overall effect would be to decrease our
likelihood of finding a difference between the arms. Also,
we are limited by the services offered by our state’s Quit-
line: performing this study in a state with a Quitline
similar to our in-house system might be less likely to
find a significant difference between the two arms.
Trial status
As of the time of manuscript submission, our trial is ac-
tively enrolling participants; we started enrollment in
July 2011.
Abbreviations
ANOVA: Analysis of variance; CHART: Consortium of Hospitals Advancing
Research on Tobacco; EMR: Electronic medical record; NRT: Nicotine
replacement therapy; QALY: Quality-adjusted life year; SP: Standardized
patient; VA: Veterans Affairs.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
All authors contributed to the design of the study and the preparation of
the manuscript. SS, DS, and EG planned the study design and obtained
funding. AG and EG are leading the team in implementing the study. ILplanned and will perform the analyses related to effectiveness. RSB designed
and will perform the cost-effectiveness analysis. ER designed and is
implementing the telephone counseling program. All authors read and
approved the final manuscript.
Acknowledgements
We would like to thank the study staff members at all of the CHART research
sites, as well as Bill Riley and other NIH personnel on the team. We also
would like to thank our local team of telephone counselors and research
assistants, and hospital personnel who have been supportive of the study
from inception.
Author details
1Division of General Internal Medicine, New York University School of
Medicine, New York, NY, USA. 2Bellevue Hospital Center, New York, NY, USA.
3New York University College of Dentistry, New York, NY, USA. 4Department
of Population Health,, New York University School of Medicine, New York,
NY, USA. 5VA New York Harbor Healthcare System, New York, NY, USA.
Received: 4 October 2011 Accepted: 8 June 2012
Published: 1 August 2012
References
1. Centers for Disease Control and Prevention (CDC): Cigarette smoking
among adults and trends in smoking cessation - United States. MMWR
2009 2008, 58:1227–1232.
2. Centers for Disease Control and Prevention (CDC): Vital signs: current
cigarette smoking among adults aged>or = 18 years - United States.
MMWR 2010 2009, 59:1135–1140.
3. Fiore MC, Jaen CR, Baker TB, Bailey WC, Benowitz NL, Curry SJ, et al: Treating
Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline.
Rockville, MD: US Department of Health and Human Services Public Health
Service; 2008.
4. Rigotti NA, Munafo MR, Stead LF: Interventions for smoking
cessation in hospitalised patients. Cochrane Database Syst Rev 2007,
18:CD001837.
5. Stead LF, Lancaster T, Perera R: Telephone counselling for smoking
cessation. Cochrane Database Syst Rev 2003, 1:CD002850.
6. Zhu SH, Anderson CM, Johnson CE, Tedeschi G, Roeseler A: A centralised
telephone service for tobacco cessation: the California experience. Tob
Control 2000, 9(Suppl 2):II48–II55.
7. Yano EM, Rubenstein LV, Chernof BA, Mittman BS, Lanto AB, Simon
BF, Lee ML, Sherman SE: Evidence-based quality improvement
strategies for tailoring implementation of smoking cessation
guidelines into routine care: impact on practice-level quit attempts
and smoking cessation. Health Serv Res 2008, 43(5 part 1):1637–1661.
8. Sherman SE, Estrada M, Lanto AB, Farmer MF, Aldana I: Effectiveness of an
on-call counselor at increasing smoking treatment. J Gen Intern Med 2007,
22:1125–1131.
9. Draft results from the 2008 North American Quitline Consortium annual survey.
http://www.naQuitline.org/resource/resmgr/survey_2008/2008surveynotespres.
pdf.
10. Marcy TW, Solomon LJ, Dana GS, Secker-Walker R, Skelly JM: A smoking
cessation telephone resource: feasibility and preliminary evidence on
the effect on health care provider adherence to smoking cessation
guidelines. Tob Control 2002, 11:84.
11. Perry RJ, Keller PA, Fraser D, Fiore MC: Fax to quit: a model for delivery
of tobacco cessation services to Wisconsin residents. WMJ 2005,
104:37–40. 44.
12. Bentz CJ, Bayley KB, Bonin KE, Fleming L, Hollis JF, McAfee T: The feasibility
of connecting physician offices to a state-level tobacco quit line. Am J
Prev Med 2006, 30:31–37.
13. Wolfenden L, Wiggers J, Campbell E, Knight J, Kerridge R, Moore K,
Spigelman A, Harrison M: Feasibility, acceptability, and cost of referring
surgical patients for postdischarge cessation support from a Quitline.
Nicotine Tob Res 2008, 10:1105–1108.
14. Rundle RL: Oft-derided veterans health agency puts data online, saving
time, lives. Wall St J 2001, 1:A1.
15. erlin JB, Kolodner RM, Roswell RH: The Veterans Health Administration:
quality, value, accountability, and information as transforming strategies
for patient-centered care. Am J Manag Care 2004, 10(11 Pt 2):828–836.
Grossman et al. Trials 2012, 13:126 Page 10 of 10
http://www.trialsjournal.com/content/13/1/12616. Halpern J: The measurement of quality of care in the Veterans Health
Administration. Med Care 1996, 34(3 Suppl):MS55–MS68.
17. Jha AK, Perlin JB, Kizer KW, Dudley RA: Effect of the transformation of the
Veterans Affairs Health Care System on the quality of care. N Engl J Med
2003, 348:2218–2227.
18. Wikipedia: New York City Health and Hospitals Corporatio: Wikipedia: New
York City Health and Hospitals Corporatio.: ; http://en.wikipedia.org/wiki/
New_York_City_Health_and_Hospitals_Corporation]. Accessed 1/10/10.
19. Riley WT, Stevens VJ, Zhu SH, Morgan G, Grossman D. Overview of the
Consortium of Hospitals Advancing Research on Tobacco (CHART). Trials 2012,
13:122.
20. Sherman SE, Fotiades J, Rubenstein LV, Gilman SC, Vivell S, Chaney E, Yano
EM, Felker B: Teaching systems-based practice to primary care physicians
to foster routine implementation of evidence-based depression care.
Acad Med 2007, 82:168–175.
21. Miller N, Frieden TR, Liu SY, Matte TD, Mostashari F, Deitcher DR, Cummings
KM, Chang C, Bauer U, Bassett MT: Effectiveness of a large-scale
distribution programme of free nicotine patches: a prospective
evaluation. Lancet 2005, 365:1849–1854.
22. Zhu SH, Pierce JP: A new scheduling method for time-limited counseling.
Professional Psychol: Res Pract 1995, 26:624–625.
23. Gold MR, Siegel JE, Russell LB, Weinstein MC: Cost-Effectiveness in Health and
Medicine. New York, NY: Oxford University Press; 1996.
24. The Joint Commission: Specifications Manual for National Hospital Inpatient
Quality Measures. http://www.jointcommission.org/
specifications_manual_for_national_hospital_inpatient_quality_measures/].
Accessed September 25, 2011.
doi:10.1186/1745-6215-13-126
Cite this article as: Grossman et al.: Effectiveness of smoking-cessation
interventions for urban hospital patients: study protocol for a
randomized controlled trial. Trials 2012 13:126.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
